← Back to headlines
Phio Pharmaceuticals Reports In-Line GAAP EPS for Quarter
Phio Pharmaceuticals announced its GAAP EPS of -$0.36, which was in line with analyst expectations for the quarter.
6 Aug, 21:26 — 6 Aug, 21:26
Sources
Showing 1 of 1 sources
